Biotech · Private company · Honolulu, HI, US

Hawaii Biotech, Inc.

Track this companyFree. Adds Hawaii Biotech, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Chikungunya Recombinant Subunit VaccineFiscal year 2025 · $998.2KNIH RePORTER 5R44AI120388-06 · fetched Nov 12, 2026
Chikungunya Recombinant Subunit VaccineFiscal year 2024 · $967.1KNIH RePORTER 2R44AI120388-05 · fetched Nov 12, 2026
Development of a Cross-Protective New World Encephalitic Alphavirus Subunit VaccineFiscal year 2024 · $203.3KNIH RePORTER 5R43AI172555-02 · fetched Nov 12, 2026
Novel TLR-4 Agonists as Vaccine AdjuvantsFiscal year 2024 · $204.9KNIH RePORTER 5R43AI174478-02 · fetched Nov 12, 2026